Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-22

Clinical Trial Update: Effect of Rematazolam Besylate, Propofol, and Sevoflurane Perioperative Sedation on Incidence of Emergence Agitation and Hemodynamics in Patients Undergoing Laparoscopic Abdominal Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of remimazolam besylate with propofol and sevoflurane perioperative sedation on emergence agitation and hemodynamics during …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROPOFOL (Propofol)
  • Remimazolam besylate (remimazolam besylate)
  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Emergence Agitation, Remimazolam Besylate | Phase 4 | Status: UNKNOWN